Company Filing History:
Years Active: 2023
Title: Huifang Su: Innovator in Cancer Cell Imaging
Introduction
Huifang Su is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer cell imaging through his innovative research and development. His work focuses on the creation of advanced luminogens that exhibit aggregation-induced emission (AIE), which has important applications in medical imaging.
Latest Patents
Huifang Su holds a patent for "AIEgens for cancer cell imaging." This patent describes a luminogen that exhibits aggregation-induced emission, wherein T1, T2, and T3 comprise one or more polyynes as a conjugated bridge. The invention also includes an AIEgen that features a hydrophilic pyridinium group as a strong electron-withdrawing group, a piperazine group as an electron-donating group, and α-Cyanostilbene. The AIEgen demonstrates aggregation-induced emission and provides methods for synthesizing the AIEgen. Additionally, it outlines a method for labeling cells by incubating a subject with a conjugate formed by conjugating an AIEgen with an antibody, allowing for selective labeling of desired cells through turn-on imaging.
Career Highlights
Huifang Su is affiliated with The Hong Kong University of Science and Technology, where he continues to advance his research in the field of cancer imaging. His innovative work has garnered attention and recognition within the scientific community.
Collaborations
Some of Huifang Su's notable coworkers include Benzhong Tang and Xiujuan Shi, who contribute to his research endeavors and collaborative projects.
Conclusion
Huifang Su's contributions to cancer cell imaging through his innovative patent demonstrate his commitment to advancing medical technology. His work not only enhances our understanding of cancer but also paves the way for improved diagnostic methods.